Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Inflammatory Breast Neoplasms × Bevacizumab × Clear all

Phase

Phase 2 6 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 60 Neoplasms 41 Carcinoma, Non-Small-Cell Lung 32 Ovarian Neoplasms 27 Neoplasm Metastasis 22 Glioblastoma 19 Lung Neoplasms 17 Fallopian Tube Neoplasms 16 Colonic Neoplasms 16 Breast Neoplasms 16 Rectal Neoplasms 15 Pancreatic Neoplasms 15 Carcinoma, Renal Cell 13 Carcinoma, Hepatocellular 12 Stomach Neoplasms 10 Glioma 10 Carcinoma, Ovarian Epithelial 8 Solid Cancers 7 Melanoma 7 Liver Neoplasms 7 Brain Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Solid Tumors 6 Sarcoma 6 Uterine Cervical Neoplasms 5 Recurrence 5 Lymphoma, Non-Hodgkin 5 Astrocytoma 5 Advanced Cancer 5 Triple Negative Breast Neoplasms 4

Interventions

Trastuzumab 3 Cyclophosphamide 3 pembrolizumab 2 Radiotherapy 2 Filgrastim 2 Epirubicin 2 Carboplatin 2 tipifarnib 1 pegfilgrastim 1 olaparib 1 aldesleukin 1 Thiotepa 1 Tamoxifen 1 Semaxinib 1 Peripheral Blood Stem Cell Transplantation 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Immunohistochemistry 1 Fluorouracil 1 Fluorescent Antibody Technique 1 Flow Cytometry 1 Doxorubicin 1 Docetaxel 1 Diathermy 1 Capecitabine 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01880385 2013-06-19

Beva

Association Tunisienne de lutte Contre le Cancer

Phase 1 Unknown

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡